Implantable graft to close a fistula

Patent metadata

Field	Value
Publication number	US-9456815-B2
Application number	US-201414465302-A
Country	US
Kind code	B2
Filing date	Aug 21, 2014
Priority date	Jun 21, 2005
Publication date	Oct 4, 2016
Grant date	Oct 4, 2016

Abstract

An implantable graft, which may be inserted into a fistula tract to occlude the primary opening of the fistula, is provided. To prevent unintentional displacement of the graft or extrusion of the graft from the fistula of a patient, the graft may be provided with a cap that extends laterally from at least one end of the body of the graft, where the cap may be integral with the body of the graft, attachable to at least one end of the body of the graft, and/or moveable along the body of the graft. The graft may also have a tail that extends from one end of the body of the graft to assist in placement of the graft in a fistula tract. The graft may be an integral unit made of a single material, such as a heterograft material, or may include distinct components made of the same or different materials. Methods for closing a fistula tract are also provided.

First claim

We claim:

1. A fistula graft for treating a patient having a fistula having an opening in a first tissue wall, an opening in a second tissue wall, and a fistula tract extending therebetween, the fistula graft comprising:
an elongate graft body having a first end and a second end, the elongate graft body comprising remodelable material selected from the group consisting of a cadaveric material from a human donor and a heterograft material from a non-human donor,
a composition comprising a concentrated composite of platelets and a growth factor, wherein the composition contacts the elongate graft body, and
a first cap, wherein the first end of the elongate graft body attaches to the first cap in a non-permanent manner.

2. The fistula graft of claim 1 , wherein the platelets and growth factors are derived from blood of the patient.

3. The fistula graft of claim 1 , wherein graft body further comprises a non-native bioactive agent.

4. The fistula graft of claim 1 , wherein the cadaveric material from a human donor or heterograft material from a non-human donor comprises a rolled or folded intact sheet of remodelable material that promotes cellular invasion and ingrowth within the sheet and reconstruction of host tissue within the sheet.

5. The fistula graft of claim 1 , wherein the cadaveric material from a human donor or heterograft material from a non-human donor is selected from the group consisting of submucosa, renal capsule membrane, dermal collagen, dura mater, pericardium, serosa, peritoneum, basement membrane layers, and liver basement membrane.

6. The fistula graft of claim 5 , wherein the cadaveric material from a human donor or heterograft material from a non-human donor is selected from the group consisting of submucosa and dermal collagen.

7. The fistula graft of claim 1 , wherein the first cap attaches to the elongate graft body by a suture.

8. The fistula graft of claim 1 , wherein the first end of the elongate graft body is larger than the second end and wherein the elongate graft body comprises a taper between the first end and the second end.

9. The fistula graft of claim 1 , wherein the first cap comprises an absorbable material.

10. The fistula graft of claim 1 , wherein the cadaveric material from a human donor or heterograft material from a non-human donor is submucosa.

11. The fistula graft of claim 1 , wherein the first cap comprises a bioresorbable polymer.

12. The fistula graft of claim 1 , wherein the cadaveric material from a human donor or heterograft material from a non-human donor comprises stacked extracellular matrix segments.

13. A fistula graft for treating a patient having a fistula having an opening in a first tissue wall, an opening in a second tissue wall, and a fistula tract extending therebetween, the fistula graft comprising:
a first cap;
an elongate graft body having a first end attached to the first cap and a second end, the elongate graft body comprising remodelable material selected from the group consisting of a cadaveric material from a human donor and a heterograft material from a non-human donor, wherein the first cap attaches to the first end of the elongate graft body in a manner resulting in detachment and release of the first cap from the elongate graft body following implantation of the fistula graft in the fistula; and
a composition comprising a concentrated composite of platelets and a growth factor, wherein the composition contacts the elongate graft body.

14. The fistula graft of claim 13 , wherein the cadaveric material from a human donor or heterograft material from a non-human donor is selected from the group consisting of submucosa and dermal collagen.

15. The fistula graft of claim 13 , wherein the first cap comprises an absorbable material.

16. The fistula graft of claim 13 , wherein the first cap comprises a synthetic polymeric material.

17. The fistula graft of claim 13 , wherein a bioabsorbable suture attaches the first end of the elongate graft body to the first cap and wherein the attachment is such that the cap detaches from the elongate graft body upon absorption of the suture.

Assignees

• Cook Biotech Inc
• Cook Medical Technologies Llc
• Cook Biotech Inc

Inventors

• Armstrong David N
• Bates Brian L
• Bleyer Mark W
• Obermiller F Joseph
• Patel Umesh H

Classifications

• A61B17/06

  Needles {; Sutures; Needle-suture combinations}; Holders or packages for needles or suture materials · CPC title

• A61L27/3633

  Extracellular matrix [ECM] · CPC title

• A61L27/24

  Collagen · CPC title

• A61M27/00

  Drainage appliance for wounds or the like {, i.e. wound drains, implanted drains} ({negative pressure wound therapy devices A61M1/90;} implements for holding wound open A61B17/02 {; middle ear drainage A61F11/202}) · CPC title

• A61B2017/00646

  Type of implements · CPC title